Byomkesh Manna

TL;DR: Interventions targeting five pathogens can substantially reduce the burden of moderate-to-severe diarrhoea and suggest new methods and accelerated implementation of existing interventions (rotavirus vaccine and zinc) are needed to prevent disease and improve outcomes.

TL;DR: There is a significant prevalence of NAFL and potentially significant liver disease, including cryptogenic cirrhosis, in this predominantly nonobese, nonaffluent population in a developing country and NAFL will be a major determinant of future liver disease burden in countries of the developing world.

TL;DR: It is concluded that ocean and climate patterns are useful predictors of cholera epidemics, with the dynamics of endemic cholERA being related to climate and/or changes in the aquatic ecosystem.

TL;DR: This modified killed-whole-cell oral vaccine, compliant with WHO standards, is safe, provides protection against clinically significant cholera in an endemic setting, and can be used in children aged 1.0-4.9 years, who are at highest risk of developing cholERA in endemic settings.

TL;DR: Sustained protection for 5 years at the level reported has not been noted previously with other oral cholera vaccines, and could assist policy makers formulate rational vaccination strategies to reduce overall cholERA burden in endemic settings.